Ledger.Open graph →
SEC Form D · Amendment · filed December 10, 2015

RHYTHM PHARMACEUTICALS, INC

Offering
$40.0M
Sold
$40.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

Jonathan T. Silverstein · New York, NYDirectorEdward T. Mathers · Timonium, MDDirectorKeith Gottesdiener · Boston, MAExec · DirectorDavid J. Mcgirr · Greenwich, CTDirectorDavid P. Meeker, M.D · Cambridge, MADirectorTodd T. Foley · Boston, MADirectorBart T. Henderson · Boston, MAExecChristophe Jean · Slough, United KingdomDirectorNeil Exter · Boston, MADirectorEric J. Klein · Menlo Park, CADirectorVincent Kim · San Francisco, CAExec · DirectorBabak N. Yazdani · San Francisco, CAExecDan Simons · Kensington, MDDirectorBabak N. Poushanchi · San Francisco, CADirectorSamuel Weatherford · Tampa, FLDirectorArvind Rajan · San Francisco, CADirectorJoel D. Brinton · Menlo Park, CADirectorWilliam Weatherford · Tampa, FLDirectorMichael Lavitola · Chicago, ILDirectorJohn Reiff · Baltimore, MDExec · DirectorJeffrey P. Cohen · IRVING, TXExecPaul A. Hughson · IRVING, TXDirectorMark Butters · Coconut Creek, FLDirectorTravis Mccourt · NEW YORK, NYDirectorRichard Rosenfield · Highland Park, ILDirectorDonald Devivo · New York, NYDirectorTriple Net Service Company, LLC · Northbrook, ILDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗